nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ALB—lung cancer	0.231	1	CbGaD
Estropipate—ALB—Gefitinib—lung cancer	0.0601	0.142	CbGbCtD
Estropipate—ALB—Erlotinib—lung cancer	0.0355	0.0842	CbGbCtD
Estropipate—CYP2C9—Gefitinib—lung cancer	0.0324	0.0768	CbGbCtD
Estropipate—ALB—Irinotecan—lung cancer	0.0321	0.0761	CbGbCtD
Estropipate—CYP2C9—Teniposide—lung cancer	0.0314	0.0745	CbGbCtD
Estropipate—CYP1A2—Erlotinib—lung cancer	0.0213	0.0504	CbGbCtD
Estropipate—CYP3A4—Topotecan—lung cancer	0.0206	0.0488	CbGbCtD
Estropipate—CYP3A4—Gefitinib—lung cancer	0.0188	0.0447	CbGbCtD
Estropipate—CYP3A4—Teniposide—lung cancer	0.0183	0.0433	CbGbCtD
Estropipate—CYP2C9—Paclitaxel—lung cancer	0.0175	0.0416	CbGbCtD
Estropipate—ALB—Methotrexate—lung cancer	0.017	0.0403	CbGbCtD
Estropipate—CYP1A2—Etoposide—lung cancer	0.0154	0.0365	CbGbCtD
Estropipate—CYP3A4—Vinorelbine—lung cancer	0.0145	0.0344	CbGbCtD
Estropipate—CYP2C9—Cisplatin—lung cancer	0.0141	0.0334	CbGbCtD
Estropipate—CYP3A4—Crizotinib—lung cancer	0.0115	0.0274	CbGbCtD
Estropipate—CYP3A4—Erlotinib—lung cancer	0.0111	0.0264	CbGbCtD
Estropipate—CYP3A4—Paclitaxel—lung cancer	0.0102	0.0242	CbGbCtD
Estropipate—CYP3A4—Irinotecan—lung cancer	0.0101	0.0238	CbGbCtD
Estropipate—CYP3A4—Vinblastine—lung cancer	0.00895	0.0212	CbGbCtD
Estropipate—CYP3A4—Etoposide—lung cancer	0.00806	0.0191	CbGbCtD
Estropipate—CYP3A4—Docetaxel—lung cancer	0.00737	0.0175	CbGbCtD
Estropipate—CYP3A4—Doxorubicin—lung cancer	0.0055	0.013	CbGbCtD
Estropipate—Conjugated Estrogens—ABCC3—lung cancer	0.0007	0.166	CrCbGaD
Estropipate—Estradiol—UGT1A1—lung cancer	0.000457	0.109	CrCbGaD
Estropipate—Conjugated Estrogens—ABCG2—lung cancer	0.00034	0.0807	CrCbGaD
Estropipate—Estrone—ABCG2—lung cancer	0.000339	0.0805	CrCbGaD
Estropipate—Estriol—ABCB1—lung cancer	0.000297	0.0704	CrCbGaD
Estropipate—Estramustine—ABCB1—lung cancer	0.000276	0.0654	CrCbGaD
Estropipate—Estrone—CYP2E1—lung cancer	0.000269	0.0639	CrCbGaD
Estropipate—Estrone—CYP1A1—lung cancer	0.000266	0.063	CrCbGaD
Estropipate—Estradiol—ABCG2—lung cancer	0.000257	0.061	CrCbGaD
Estropipate—Estradiol—CYP1A1—lung cancer	0.000201	0.0478	CrCbGaD
Estropipate—Ethinyl Estradiol—ABCB1—lung cancer	0.000162	0.0384	CrCbGaD
Estropipate—Estrone—ALB—lung cancer	0.000148	0.0351	CrCbGaD
Estropipate—Conjugated Estrogens—ABCB1—lung cancer	0.000142	0.0336	CrCbGaD
Estropipate—Estrone—ABCB1—lung cancer	0.000141	0.0335	CrCbGaD
Estropipate—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000125	0.000559	CcSEcCtD
Estropipate—Abdominal discomfort—Methotrexate—lung cancer	0.000125	0.000558	CcSEcCtD
Estropipate—Fatigue—Gemcitabine—lung cancer	0.000125	0.000558	CcSEcCtD
Estropipate—Pain—Gemcitabine—lung cancer	0.000124	0.000553	CcSEcCtD
Estropipate—Constipation—Gemcitabine—lung cancer	0.000124	0.000553	CcSEcCtD
Estropipate—Nausea—Erlotinib—lung cancer	0.000124	0.000553	CcSEcCtD
Estropipate—Anaphylactic shock—Etoposide—lung cancer	0.000123	0.000553	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—lung cancer	0.000123	0.000552	CcSEcCtD
Estropipate—Diarrhoea—Vinorelbine—lung cancer	0.000123	0.000551	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000123	0.00055	CcSEcCtD
Estropipate—Infection—Etoposide—lung cancer	0.000123	0.000549	CcSEcCtD
Estropipate—Back pain—Docetaxel—lung cancer	0.000121	0.000544	CcSEcCtD
Estropipate—Dysuria—Methotrexate—lung cancer	0.000121	0.000544	CcSEcCtD
Estropipate—Gastrointestinal pain—Irinotecan—lung cancer	0.000121	0.000543	CcSEcCtD
Estropipate—Anaphylactic shock—Paclitaxel—lung cancer	0.000121	0.000542	CcSEcCtD
Estropipate—Oedema—Paclitaxel—lung cancer	0.000121	0.000542	CcSEcCtD
Estropipate—Paraesthesia—Cisplatin—lung cancer	0.000121	0.000542	CcSEcCtD
Estropipate—Muscle spasms—Docetaxel—lung cancer	0.000121	0.000541	CcSEcCtD
Estropipate—Upper respiratory tract infection—Methotrexate—lung cancer	0.000121	0.000541	CcSEcCtD
Estropipate—Infection—Paclitaxel—lung cancer	0.00012	0.000538	CcSEcCtD
Estropipate—Skin disorder—Etoposide—lung cancer	0.00012	0.000537	CcSEcCtD
Estropipate—Dizziness—Vinorelbine—lung cancer	0.000119	0.000533	CcSEcCtD
Estropipate—Nervous system disorder—Paclitaxel—lung cancer	0.000119	0.000531	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—lung cancer	0.000118	0.000527	CcSEcCtD
Estropipate—Skin disorder—Paclitaxel—lung cancer	0.000117	0.000526	CcSEcCtD
Estropipate—Abdominal pain—Irinotecan—lung cancer	0.000117	0.000525	CcSEcCtD
Estropipate—Body temperature increased—Irinotecan—lung cancer	0.000117	0.000525	CcSEcCtD
Estropipate—Gastrointestinal disorder—Cisplatin—lung cancer	0.000116	0.000521	CcSEcCtD
Estropipate—Infestation—Methotrexate—lung cancer	0.000116	0.000519	CcSEcCtD
Estropipate—Infestation NOS—Methotrexate—lung cancer	0.000116	0.000519	CcSEcCtD
Estropipate—Depression—Methotrexate—lung cancer	0.000115	0.000517	CcSEcCtD
Estropipate—Pain—Cisplatin—lung cancer	0.000115	0.000516	CcSEcCtD
Estropipate—Vomiting—Vinorelbine—lung cancer	0.000114	0.000512	CcSEcCtD
Estropipate—Body temperature increased—Gemcitabine—lung cancer	0.000114	0.000512	CcSEcCtD
Estropipate—Rash—Vinorelbine—lung cancer	0.000113	0.000508	CcSEcCtD
Estropipate—Dermatitis—Vinorelbine—lung cancer	0.000113	0.000507	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—lung cancer	0.000113	0.000507	CcSEcCtD
Estropipate—Headache—Vinorelbine—lung cancer	0.000113	0.000505	CcSEcCtD
Estropipate—Asthma—Doxorubicin—lung cancer	0.000112	0.000504	CcSEcCtD
Estropipate—Influenza—Doxorubicin—lung cancer	0.000112	0.000504	CcSEcCtD
Estropipate—Estradiol—ALB—lung cancer	0.000112	0.0266	CrCbGaD
Estropipate—Palpitations—Docetaxel—lung cancer	0.000111	0.000497	CcSEcCtD
Estropipate—Paraesthesia—Etoposide—lung cancer	0.000111	0.000496	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—lung cancer	0.00011	0.000494	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00011	0.000494	CcSEcCtD
Estropipate—Somnolence—Etoposide—lung cancer	0.00011	0.000491	CcSEcCtD
Estropipate—Cough—Docetaxel—lung cancer	0.00011	0.000491	CcSEcCtD
Estropipate—Hepatobiliary disease—Methotrexate—lung cancer	0.00011	0.000491	CcSEcCtD
Estropipate—Insomnia—Paclitaxel—lung cancer	0.000109	0.00049	CcSEcCtD
Estropipate—Hypersensitivity—Irinotecan—lung cancer	0.000109	0.000489	CcSEcCtD
Estropipate—Paraesthesia—Paclitaxel—lung cancer	0.000109	0.000487	CcSEcCtD
Estropipate—Somnolence—Paclitaxel—lung cancer	0.000108	0.000482	CcSEcCtD
Estropipate—Estradiol—ABCB1—lung cancer	0.000107	0.0254	CrCbGaD
Estropipate—Arthralgia—Docetaxel—lung cancer	0.000107	0.000479	CcSEcCtD
Estropipate—Myalgia—Docetaxel—lung cancer	0.000107	0.000479	CcSEcCtD
Estropipate—Nausea—Vinorelbine—lung cancer	0.000107	0.000478	CcSEcCtD
Estropipate—Gastrointestinal disorder—Etoposide—lung cancer	0.000106	0.000477	CcSEcCtD
Estropipate—Dyspepsia—Paclitaxel—lung cancer	0.000106	0.000477	CcSEcCtD
Estropipate—Body temperature increased—Cisplatin—lung cancer	0.000106	0.000477	CcSEcCtD
Estropipate—Asthenia—Irinotecan—lung cancer	0.000106	0.000477	CcSEcCtD
Estropipate—Fatigue—Etoposide—lung cancer	0.000106	0.000476	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000106	0.000476	CcSEcCtD
Estropipate—Pain—Etoposide—lung cancer	0.000105	0.000473	CcSEcCtD
Estropipate—Constipation—Etoposide—lung cancer	0.000105	0.000473	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—lung cancer	0.000105	0.000471	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000105	0.000468	CcSEcCtD
Estropipate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000104	0.000468	CcSEcCtD
Estropipate—Fatigue—Paclitaxel—lung cancer	0.000104	0.000467	CcSEcCtD
Estropipate—Asthenia—Gemcitabine—lung cancer	0.000104	0.000464	CcSEcCtD
Estropipate—Pain—Paclitaxel—lung cancer	0.000103	0.000463	CcSEcCtD
Estropipate—Constipation—Paclitaxel—lung cancer	0.000103	0.000463	CcSEcCtD
Estropipate—Pharyngitis—Methotrexate—lung cancer	0.000103	0.000462	CcSEcCtD
Estropipate—Anaphylactic shock—Docetaxel—lung cancer	0.000102	0.000459	CcSEcCtD
Estropipate—Oedema—Docetaxel—lung cancer	0.000102	0.000459	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—lung cancer	0.000102	0.000459	CcSEcCtD
Estropipate—Pruritus—Gemcitabine—lung cancer	0.000102	0.000458	CcSEcCtD
Estropipate—Infection—Docetaxel—lung cancer	0.000102	0.000456	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—lung cancer	0.000101	0.000455	CcSEcCtD
Estropipate—Diarrhoea—Irinotecan—lung cancer	0.000101	0.000455	CcSEcCtD
Estropipate—Gastrointestinal pain—Etoposide—lung cancer	0.000101	0.000452	CcSEcCtD
Estropipate—Nervous system disorder—Docetaxel—lung cancer	0.000101	0.00045	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—lung cancer	0.0001	0.000449	CcSEcCtD
Estropipate—Infestation—Doxorubicin—lung cancer	0.0001	0.000449	CcSEcCtD
Estropipate—Visual impairment—Methotrexate—lung cancer	0.0001	0.000449	CcSEcCtD
Estropipate—Skin disorder—Docetaxel—lung cancer	9.96e-05	0.000446	CcSEcCtD
Estropipate—Hypersensitivity—Cisplatin—lung cancer	9.92e-05	0.000444	CcSEcCtD
Estropipate—Gastrointestinal pain—Paclitaxel—lung cancer	9.89e-05	0.000443	CcSEcCtD
Estropipate—Diarrhoea—Gemcitabine—lung cancer	9.88e-05	0.000443	CcSEcCtD
Estropipate—Erythema multiforme—Methotrexate—lung cancer	9.83e-05	0.000441	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—lung cancer	9.83e-05	0.000441	CcSEcCtD
Estropipate—Dizziness—Irinotecan—lung cancer	9.81e-05	0.000439	CcSEcCtD
Estropipate—Urticaria—Etoposide—lung cancer	9.8e-05	0.000439	CcSEcCtD
Estropipate—Body temperature increased—Etoposide—lung cancer	9.75e-05	0.000437	CcSEcCtD
Estropipate—Abdominal pain—Etoposide—lung cancer	9.75e-05	0.000437	CcSEcCtD
Estropipate—Eye disorder—Methotrexate—lung cancer	9.72e-05	0.000435	CcSEcCtD
Estropipate—Asthenia—Cisplatin—lung cancer	9.66e-05	0.000433	CcSEcCtD
Estropipate—Cardiac disorder—Methotrexate—lung cancer	9.65e-05	0.000432	CcSEcCtD
Estropipate—Urticaria—Paclitaxel—lung cancer	9.61e-05	0.00043	CcSEcCtD
Estropipate—Body temperature increased—Paclitaxel—lung cancer	9.56e-05	0.000428	CcSEcCtD
Estropipate—Abdominal pain—Paclitaxel—lung cancer	9.56e-05	0.000428	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—lung cancer	9.49e-05	0.000425	CcSEcCtD
Estropipate—Angiopathy—Methotrexate—lung cancer	9.43e-05	0.000423	CcSEcCtD
Estropipate—Vomiting—Irinotecan—lung cancer	9.43e-05	0.000422	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—lung cancer	9.41e-05	0.000422	CcSEcCtD
Estropipate—Immune system disorder—Methotrexate—lung cancer	9.39e-05	0.000421	CcSEcCtD
Estropipate—Mediastinal disorder—Methotrexate—lung cancer	9.37e-05	0.00042	CcSEcCtD
Estropipate—Rash—Irinotecan—lung cancer	9.35e-05	0.000419	CcSEcCtD
Estropipate—Dermatitis—Irinotecan—lung cancer	9.34e-05	0.000418	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Docetaxel—lung cancer	9.34e-05	0.000418	CcSEcCtD
Estropipate—Headache—Irinotecan—lung cancer	9.29e-05	0.000416	CcSEcCtD
Estropipate—Insomnia—Docetaxel—lung cancer	9.27e-05	0.000415	CcSEcCtD
Estropipate—Diarrhoea—Cisplatin—lung cancer	9.21e-05	0.000413	CcSEcCtD
Estropipate—Paraesthesia—Docetaxel—lung cancer	9.2e-05	0.000412	CcSEcCtD
Estropipate—Alopecia—Methotrexate—lung cancer	9.19e-05	0.000412	CcSEcCtD
Estropipate—Vomiting—Gemcitabine—lung cancer	9.18e-05	0.000411	CcSEcCtD
Estropipate—Somnolence—Docetaxel—lung cancer	9.11e-05	0.000408	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—lung cancer	9.11e-05	0.000408	CcSEcCtD
Estropipate—Rash—Gemcitabine—lung cancer	9.11e-05	0.000408	CcSEcCtD
Estropipate—Dermatitis—Gemcitabine—lung cancer	9.1e-05	0.000408	CcSEcCtD
Estropipate—Hypersensitivity—Etoposide—lung cancer	9.09e-05	0.000407	CcSEcCtD
Estropipate—Erythema—Methotrexate—lung cancer	9.05e-05	0.000406	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—lung cancer	9.05e-05	0.000406	CcSEcCtD
Estropipate—Headache—Gemcitabine—lung cancer	9.05e-05	0.000405	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—lung cancer	9.03e-05	0.000404	CcSEcCtD
Estropipate—Dyspepsia—Docetaxel—lung cancer	9.02e-05	0.000404	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—lung cancer	8.94e-05	0.0004	CcSEcCtD
Estropipate—Hypersensitivity—Paclitaxel—lung cancer	8.91e-05	0.000399	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—lung cancer	8.87e-05	0.000397	CcSEcCtD
Estropipate—Gastrointestinal disorder—Docetaxel—lung cancer	8.85e-05	0.000396	CcSEcCtD
Estropipate—Asthenia—Etoposide—lung cancer	8.85e-05	0.000396	CcSEcCtD
Estropipate—Fatigue—Docetaxel—lung cancer	8.84e-05	0.000396	CcSEcCtD
Estropipate—Nausea—Irinotecan—lung cancer	8.81e-05	0.000395	CcSEcCtD
Estropipate—Constipation—Docetaxel—lung cancer	8.77e-05	0.000393	CcSEcCtD
Estropipate—Pain—Docetaxel—lung cancer	8.77e-05	0.000393	CcSEcCtD
Estropipate—Back pain—Methotrexate—lung cancer	8.76e-05	0.000392	CcSEcCtD
Estropipate—Pruritus—Etoposide—lung cancer	8.73e-05	0.000391	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—lung cancer	8.68e-05	0.000389	CcSEcCtD
Estropipate—Asthenia—Paclitaxel—lung cancer	8.68e-05	0.000389	CcSEcCtD
Estropipate—Nausea—Gemcitabine—lung cancer	8.58e-05	0.000384	CcSEcCtD
Estropipate—Vomiting—Cisplatin—lung cancer	8.56e-05	0.000384	CcSEcCtD
Estropipate—Pruritus—Paclitaxel—lung cancer	8.56e-05	0.000383	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—lung cancer	8.51e-05	0.000381	CcSEcCtD
Estropipate—Rash—Cisplatin—lung cancer	8.49e-05	0.00038	CcSEcCtD
Estropipate—Dermatitis—Cisplatin—lung cancer	8.48e-05	0.00038	CcSEcCtD
Estropipate—Diarrhoea—Etoposide—lung cancer	8.44e-05	0.000378	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—lung cancer	8.41e-05	0.000377	CcSEcCtD
Estropipate—Gastrointestinal pain—Docetaxel—lung cancer	8.38e-05	0.000376	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—lung cancer	8.36e-05	0.000374	CcSEcCtD
Estropipate—Diarrhoea—Paclitaxel—lung cancer	8.27e-05	0.000371	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—lung cancer	8.17e-05	0.000366	CcSEcCtD
Estropipate—Dizziness—Etoposide—lung cancer	8.16e-05	0.000365	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—lung cancer	8.13e-05	0.000364	CcSEcCtD
Estropipate—Vertigo—Methotrexate—lung cancer	8.13e-05	0.000364	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—lung cancer	8.11e-05	0.000364	CcSEcCtD
Estropipate—Abdominal pain—Docetaxel—lung cancer	8.1e-05	0.000363	CcSEcCtD
Estropipate—Body temperature increased—Docetaxel—lung cancer	8.1e-05	0.000363	CcSEcCtD
Estropipate—Dizziness—Paclitaxel—lung cancer	8e-05	0.000358	CcSEcCtD
Estropipate—Nausea—Cisplatin—lung cancer	8e-05	0.000358	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—lung cancer	7.96e-05	0.000356	CcSEcCtD
Estropipate—Cough—Methotrexate—lung cancer	7.9e-05	0.000354	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—lung cancer	7.89e-05	0.000353	CcSEcCtD
Estropipate—Vomiting—Etoposide—lung cancer	7.84e-05	0.000351	CcSEcCtD
Estropipate—Erythema—Doxorubicin—lung cancer	7.84e-05	0.000351	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—lung cancer	7.84e-05	0.000351	CcSEcCtD
Estropipate—Rash—Etoposide—lung cancer	7.78e-05	0.000348	CcSEcCtD
Estropipate—Dermatitis—Etoposide—lung cancer	7.77e-05	0.000348	CcSEcCtD
Estropipate—Headache—Etoposide—lung cancer	7.73e-05	0.000346	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—lung cancer	7.72e-05	0.000346	CcSEcCtD
Estropipate—Myalgia—Methotrexate—lung cancer	7.71e-05	0.000345	CcSEcCtD
Estropipate—Arthralgia—Methotrexate—lung cancer	7.71e-05	0.000345	CcSEcCtD
Estropipate—Tension—Doxorubicin—lung cancer	7.69e-05	0.000345	CcSEcCtD
Estropipate—Vomiting—Paclitaxel—lung cancer	7.69e-05	0.000344	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.65e-05	0.000343	CcSEcCtD
Estropipate—Rash—Paclitaxel—lung cancer	7.62e-05	0.000342	CcSEcCtD
Estropipate—Dermatitis—Paclitaxel—lung cancer	7.62e-05	0.000341	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—lung cancer	7.61e-05	0.000341	CcSEcCtD
Estropipate—Back pain—Doxorubicin—lung cancer	7.58e-05	0.00034	CcSEcCtD
Estropipate—Headache—Paclitaxel—lung cancer	7.58e-05	0.000339	CcSEcCtD
Estropipate—Hypersensitivity—Docetaxel—lung cancer	7.55e-05	0.000338	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—lung cancer	7.54e-05	0.000338	CcSEcCtD
Estropipate—Anaphylactic shock—Methotrexate—lung cancer	7.39e-05	0.000331	CcSEcCtD
Estropipate—Asthenia—Docetaxel—lung cancer	7.35e-05	0.000329	CcSEcCtD
Estropipate—Infection—Methotrexate—lung cancer	7.34e-05	0.000329	CcSEcCtD
Estropipate—Nausea—Etoposide—lung cancer	7.33e-05	0.000328	CcSEcCtD
Estropipate—Pruritus—Docetaxel—lung cancer	7.25e-05	0.000325	CcSEcCtD
Estropipate—Nervous system disorder—Methotrexate—lung cancer	7.24e-05	0.000325	CcSEcCtD
Estropipate—Nausea—Paclitaxel—lung cancer	7.18e-05	0.000322	CcSEcCtD
Estropipate—Skin disorder—Methotrexate—lung cancer	7.18e-05	0.000322	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—lung cancer	7.04e-05	0.000316	CcSEcCtD
Estropipate—Diarrhoea—Docetaxel—lung cancer	7.01e-05	0.000314	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—lung cancer	6.93e-05	0.00031	CcSEcCtD
Estropipate—Cough—Doxorubicin—lung cancer	6.84e-05	0.000306	CcSEcCtD
Estropipate—Dizziness—Docetaxel—lung cancer	6.78e-05	0.000304	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Methotrexate—lung cancer	6.73e-05	0.000302	CcSEcCtD
Estropipate—Insomnia—Methotrexate—lung cancer	6.68e-05	0.000299	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—lung cancer	6.67e-05	0.000299	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—lung cancer	6.67e-05	0.000299	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—lung cancer	6.65e-05	0.000298	CcSEcCtD
Estropipate—Paraesthesia—Methotrexate—lung cancer	6.63e-05	0.000297	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.63e-05	0.000297	CcSEcCtD
Estropipate—Somnolence—Methotrexate—lung cancer	6.57e-05	0.000294	CcSEcCtD
Estropipate—Vomiting—Docetaxel—lung cancer	6.52e-05	0.000292	CcSEcCtD
Estropipate—Dyspepsia—Methotrexate—lung cancer	6.5e-05	0.000291	CcSEcCtD
Estropipate—Rash—Docetaxel—lung cancer	6.46e-05	0.00029	CcSEcCtD
Estropipate—Dermatitis—Docetaxel—lung cancer	6.46e-05	0.000289	CcSEcCtD
Estropipate—Headache—Docetaxel—lung cancer	6.42e-05	0.000288	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—lung cancer	6.4e-05	0.000287	CcSEcCtD
Estropipate—Oedema—Doxorubicin—lung cancer	6.4e-05	0.000287	CcSEcCtD
Estropipate—Gastrointestinal disorder—Methotrexate—lung cancer	6.38e-05	0.000286	CcSEcCtD
Estropipate—Fatigue—Methotrexate—lung cancer	6.37e-05	0.000285	CcSEcCtD
Estropipate—Infection—Doxorubicin—lung cancer	6.36e-05	0.000285	CcSEcCtD
Estropipate—Pain—Methotrexate—lung cancer	6.32e-05	0.000283	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—lung cancer	6.27e-05	0.000281	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—lung cancer	6.21e-05	0.000278	CcSEcCtD
Estropipate—Nausea—Docetaxel—lung cancer	6.09e-05	0.000273	CcSEcCtD
Estropipate—Gastrointestinal pain—Methotrexate—lung cancer	6.04e-05	0.000271	CcSEcCtD
Estropipate—Urticaria—Methotrexate—lung cancer	5.87e-05	0.000263	CcSEcCtD
Estropipate—Abdominal pain—Methotrexate—lung cancer	5.84e-05	0.000262	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—lung cancer	5.84e-05	0.000262	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.83e-05	0.000261	CcSEcCtD
Estropipate—Insomnia—Doxorubicin—lung cancer	5.79e-05	0.000259	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—lung cancer	5.74e-05	0.000257	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—lung cancer	5.69e-05	0.000255	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—lung cancer	5.63e-05	0.000252	CcSEcCtD
Estropipate—Gastrointestinal disorder—Doxorubicin—lung cancer	5.52e-05	0.000247	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—lung cancer	5.52e-05	0.000247	CcSEcCtD
Estropipate—Pain—Doxorubicin—lung cancer	5.47e-05	0.000245	CcSEcCtD
Estropipate—Constipation—Doxorubicin—lung cancer	5.47e-05	0.000245	CcSEcCtD
Estropipate—Hypersensitivity—Methotrexate—lung cancer	5.44e-05	0.000244	CcSEcCtD
Estropipate—Asthenia—Methotrexate—lung cancer	5.3e-05	0.000237	CcSEcCtD
Estropipate—Gastrointestinal pain—Doxorubicin—lung cancer	5.23e-05	0.000234	CcSEcCtD
Estropipate—Pruritus—Methotrexate—lung cancer	5.23e-05	0.000234	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—lung cancer	5.08e-05	0.000228	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—lung cancer	5.06e-05	0.000227	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—lung cancer	5.06e-05	0.000227	CcSEcCtD
Estropipate—Diarrhoea—Methotrexate—lung cancer	5.05e-05	0.000226	CcSEcCtD
Estropipate—Dizziness—Methotrexate—lung cancer	4.89e-05	0.000219	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—lung cancer	4.71e-05	0.000211	CcSEcCtD
Estropipate—Vomiting—Methotrexate—lung cancer	4.7e-05	0.00021	CcSEcCtD
Estropipate—Rash—Methotrexate—lung cancer	4.66e-05	0.000209	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—lung cancer	4.65e-05	0.000209	CcSEcCtD
Estropipate—Headache—Methotrexate—lung cancer	4.63e-05	0.000207	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—lung cancer	4.59e-05	0.000206	CcSEcCtD
Estropipate—Pruritus—Doxorubicin—lung cancer	4.53e-05	0.000203	CcSEcCtD
Estropipate—Nausea—Methotrexate—lung cancer	4.39e-05	0.000197	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—lung cancer	4.38e-05	0.000196	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—lung cancer	4.23e-05	0.00019	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—lung cancer	4.07e-05	0.000182	CcSEcCtD
Estropipate—Rash—Doxorubicin—lung cancer	4.03e-05	0.000181	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—lung cancer	4.03e-05	0.000181	CcSEcCtD
Estropipate—Headache—Doxorubicin—lung cancer	4.01e-05	0.00018	CcSEcCtD
Estropipate—Nausea—Doxorubicin—lung cancer	3.8e-05	0.00017	CcSEcCtD
Estropipate—SLC22A1—Metabolism—GSTM1—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.22e-05	0.000102	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTA2—lung cancer	1.22e-05	0.000102	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AVP—lung cancer	1.21e-05	0.000101	CbGpPWpGaD
Estropipate—ALB—Metabolism—ENO1—lung cancer	1.21e-05	0.000101	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—CREBBP—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP2A7—lung cancer	1.18e-05	9.89e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—RAF1—lung cancer	1.18e-05	9.86e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTA1—lung cancer	1.17e-05	9.83e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALDOA—lung cancer	1.17e-05	9.82e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF1R—lung cancer	1.16e-05	9.73e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP1A1—lung cancer	1.16e-05	9.72e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCC3—lung cancer	1.16e-05	9.72e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SDC4—lung cancer	1.16e-05	9.68e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ERCC2—lung cancer	1.15e-05	9.64e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CB—lung cancer	1.15e-05	9.63e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HES1—lung cancer	1.14e-05	9.56e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NCOA3—lung cancer	1.14e-05	9.53e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKR1C1—lung cancer	1.12e-05	9.41e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.12e-05	9.36e-05	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	1.11e-05	9.3e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ADCY1—lung cancer	1.11e-05	9.27e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ABCG2—lung cancer	1.11e-05	9.27e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—UGT1A1—lung cancer	1.09e-05	9.14e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ENO2—lung cancer	1.09e-05	9.09e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—HPGDS—lung cancer	1.09e-05	9.09e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP2E1—lung cancer	1.08e-05	9.05e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.08e-05	9.03e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—NQO1—lung cancer	1.07e-05	8.95e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.06e-05	8.91e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—lung cancer	1.06e-05	8.84e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA3—lung cancer	1.05e-05	8.82e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—RRM1—lung cancer	1.05e-05	8.82e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTT1—lung cancer	1.05e-05	8.82e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GNG11—lung cancer	1.05e-05	8.81e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.05e-05	8.77e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.05e-05	8.76e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB3—lung cancer	1.04e-05	8.74e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GCLC—lung cancer	1.04e-05	8.71e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP2A6—lung cancer	1.04e-05	8.71e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.04e-05	8.69e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.04e-05	8.68e-05	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	1.02e-05	8.54e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALDOA—lung cancer	1e-05	8.39e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TERT—lung cancer	1e-05	8.37e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—APOA1—lung cancer	9.96e-06	8.34e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—B4GALT5—lung cancer	9.9e-06	8.29e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ENO1—lung cancer	9.87e-06	8.26e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.83e-06	8.23e-05	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—lung cancer	9.81e-06	8.21e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NCOA3—lung cancer	9.72e-06	8.14e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGFR1—lung cancer	9.71e-06	8.13e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.7e-06	8.13e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—STK11—lung cancer	9.64e-06	8.07e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA4—lung cancer	9.63e-06	8.07e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HIF1A—lung cancer	9.56e-06	8.01e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.56e-06	8e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—EP300—lung cancer	9.48e-06	7.93e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCG2—lung cancer	9.46e-06	7.92e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ADCY1—lung cancer	9.46e-06	7.92e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA2—lung cancer	9.39e-06	7.86e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HPGDS—lung cancer	9.28e-06	7.77e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ENO2—lung cancer	9.28e-06	7.77e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APOA1—lung cancer	9.23e-06	7.73e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPP2R1B—lung cancer	9.22e-06	7.72e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SRC—lung cancer	9.21e-06	7.72e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KDR—lung cancer	9.15e-06	7.66e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.1e-06	7.62e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CG—lung cancer	9.1e-06	7.62e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA1—lung cancer	9.06e-06	7.58e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.05e-06	7.57e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTT1—lung cancer	9e-06	7.53e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—lung cancer	8.97e-06	7.51e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCC3—lung cancer	8.96e-06	7.5e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTP1—lung cancer	8.92e-06	7.47e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP2A6—lung cancer	8.89e-06	7.45e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GCLC—lung cancer	8.89e-06	7.45e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NRAS—lung cancer	8.87e-06	7.42e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.86e-06	7.42e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP2E1—lung cancer	8.85e-06	7.41e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NQO1—lung cancer	8.75e-06	7.33e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CAT—lung cancer	8.68e-06	7.27e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKR1C1—lung cancer	8.67e-06	7.26e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—POMC—lung cancer	8.66e-06	7.25e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.63e-06	7.22e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.57e-06	7.17e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.49e-06	7.11e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK3—lung cancer	8.49e-06	7.11e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—ABCB1—lung cancer	8.44e-06	7.07e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CREBBP—lung cancer	8.43e-06	7.06e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ENO1—lung cancer	8.43e-06	7.06e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CG—lung cancer	8.43e-06	7.05e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APC—lung cancer	8.43e-06	7.05e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KIT—lung cancer	8.43e-06	7.05e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—UGT1A1—lung cancer	8.42e-06	7.05e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.4e-06	7.03e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGF—lung cancer	8.33e-06	6.97e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.29e-06	6.94e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—TYMS—lung cancer	8.29e-06	6.94e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTM1—lung cancer	8.19e-06	6.86e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GNG11—lung cancer	8.12e-06	6.8e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—POMC—lung cancer	8.02e-06	6.71e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CD—lung cancer	8e-06	6.69e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BRAF—lung cancer	7.92e-06	6.63e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ALB—lung cancer	7.89e-06	6.61e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—STK11—lung cancer	7.89e-06	6.6e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6R—lung cancer	7.82e-06	6.55e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CREBBP—lung cancer	7.81e-06	6.54e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP1A1—lung cancer	7.77e-06	6.5e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALDOA—lung cancer	7.73e-06	6.47e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—ERCC2—lung cancer	7.7e-06	6.45e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—lung cancer	7.63e-06	6.39e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP2E1—lung cancer	7.56e-06	6.33e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NCOA3—lung cancer	7.51e-06	6.28e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NQO1—lung cancer	7.48e-06	6.26e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAP2K1—lung cancer	7.46e-06	6.24e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CD—lung cancer	7.41e-06	6.2e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.4e-06	6.2e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MAPK3—lung cancer	7.33e-06	6.14e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.32e-06	6.13e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ADCY1—lung cancer	7.3e-06	6.11e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCG2—lung cancer	7.3e-06	6.11e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTP1—lung cancer	7.3e-06	6.11e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.26e-06	6.07e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HPGDS—lung cancer	7.16e-06	5.99e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ENO2—lung cancer	7.16e-06	5.99e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—lung cancer	7.13e-06	5.97e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.11e-06	5.96e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CAT—lung cancer	7.1e-06	5.95e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.06e-06	5.91e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—lung cancer	7.01e-06	5.87e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CB—lung cancer	6.97e-06	5.84e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTT1—lung cancer	6.94e-06	5.81e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ABCB1—lung cancer	6.91e-06	5.78e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—lung cancer	6.91e-06	5.78e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP2A6—lung cancer	6.86e-06	5.75e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GCLC—lung cancer	6.86e-06	5.75e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TYMS—lung cancer	6.79e-06	5.68e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—lung cancer	6.78e-06	5.68e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—STK11—lung cancer	6.74e-06	5.64e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTM1—lung cancer	6.71e-06	5.62e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—APOA1—lung cancer	6.66e-06	5.58e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MDM2—lung cancer	6.64e-06	5.56e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RAF1—lung cancer	6.61e-06	5.54e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB2—lung cancer	6.54e-06	5.48e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ENO1—lung cancer	6.51e-06	5.45e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—lung cancer	6.49e-06	5.43e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MTOR—lung cancer	6.46e-06	5.41e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CB—lung cancer	6.46e-06	5.41e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.38e-06	5.34e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1A1—lung cancer	6.36e-06	5.32e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.33e-06	5.3e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ERCC2—lung cancer	6.31e-06	5.28e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTP1—lung cancer	6.24e-06	5.22e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL8—lung cancer	6.2e-06	5.19e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CG—lung cancer	6.08e-06	5.09e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CAT—lung cancer	6.07e-06	5.08e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.03e-06	5.05e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—lung cancer	6.02e-06	5.04e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP3—lung cancer	5.94e-06	4.97e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—lung cancer	5.93e-06	4.96e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCB1—lung cancer	5.9e-06	4.94e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP2E1—lung cancer	5.84e-06	4.89e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TYMS—lung cancer	5.8e-06	4.85e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—POMC—lung cancer	5.79e-06	4.85e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—lung cancer	5.78e-06	4.84e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NQO1—lung cancer	5.77e-06	4.83e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JUN—lung cancer	5.77e-06	4.83e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—EP300—lung cancer	5.74e-06	4.81e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTM1—lung cancer	5.73e-06	4.8e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—lung cancer	5.73e-06	4.79e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CREBBP—lung cancer	5.64e-06	4.72e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—lung cancer	5.61e-06	4.7e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1A—lung cancer	5.59e-06	4.68e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—lung cancer	5.58e-06	4.67e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—APOA1—lung cancer	5.46e-06	4.57e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP1A1—lung cancer	5.43e-06	4.55e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ERCC2—lung cancer	5.39e-06	4.51e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CD—lung cancer	5.35e-06	4.48e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EP300—lung cancer	5.32e-06	4.45e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.22e-06	4.37e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—STK11—lung cancer	5.2e-06	4.36e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SRC—lung cancer	5.17e-06	4.33e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—lung cancer	5.04e-06	4.22e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—lung cancer	4.99e-06	4.18e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CG—lung cancer	4.98e-06	4.17e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRAS—lung cancer	4.98e-06	4.17e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—lung cancer	4.94e-06	4.14e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTP1—lung cancer	4.81e-06	4.03e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK3—lung cancer	4.77e-06	3.99e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—POMC—lung cancer	4.74e-06	3.97e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CAT—lung cancer	4.68e-06	3.92e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CB—lung cancer	4.66e-06	3.9e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—APOA1—lung cancer	4.66e-06	3.9e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—lung cancer	4.64e-06	3.88e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—lung cancer	4.62e-06	3.87e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CREBBP—lung cancer	4.62e-06	3.87e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCB1—lung cancer	4.56e-06	3.82e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—lung cancer	4.53e-06	3.8e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TYMS—lung cancer	4.48e-06	3.75e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.46e-06	3.74e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTM1—lung cancer	4.42e-06	3.7e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CD—lung cancer	4.38e-06	3.67e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALB—lung cancer	4.32e-06	3.62e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—lung cancer	4.28e-06	3.59e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CG—lung cancer	4.26e-06	3.56e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—lung cancer	4.25e-06	3.56e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1A1—lung cancer	4.19e-06	3.51e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ERCC2—lung cancer	4.16e-06	3.48e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—POMC—lung cancer	4.05e-06	3.39e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—lung cancer	4.03e-06	3.37e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CREBBP—lung cancer	3.95e-06	3.3e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—lung cancer	3.94e-06	3.3e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—EP300—lung cancer	3.84e-06	3.22e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CB—lung cancer	3.82e-06	3.2e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—lung cancer	3.81e-06	3.19e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—lung cancer	3.78e-06	3.17e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CD—lung cancer	3.74e-06	3.13e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALB—lung cancer	3.69e-06	3.09e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—lung cancer	3.64e-06	3.05e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—APOA1—lung cancer	3.6e-06	3.01e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—lung cancer	3.48e-06	2.92e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—lung cancer	3.47e-06	2.91e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—lung cancer	3.3e-06	2.76e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CG—lung cancer	3.28e-06	2.75e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CB—lung cancer	3.26e-06	2.73e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—lung cancer	3.23e-06	2.71e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—lung cancer	3.22e-06	2.69e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—EP300—lung cancer	3.14e-06	2.63e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—POMC—lung cancer	3.13e-06	2.62e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CREBBP—lung cancer	3.05e-06	2.55e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CD—lung cancer	2.89e-06	2.42e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALB—lung cancer	2.85e-06	2.39e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—lung cancer	2.84e-06	2.38e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—lung cancer	2.82e-06	2.36e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—EP300—lung cancer	2.69e-06	2.25e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CB—lung cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—lung cancer	2.49e-06	2.09e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—lung cancer	2.33e-06	1.95e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—lung cancer	2.32e-06	1.94e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—lung cancer	2.17e-06	1.82e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—EP300—lung cancer	2.07e-06	1.74e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—lung cancer	1.99e-06	1.66e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—lung cancer	1.9e-06	1.59e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—lung cancer	1.62e-06	1.36e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—lung cancer	1.53e-06	1.28e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—lung cancer	1.25e-06	1.05e-05	CbGpPWpGaD
